260 related articles for article (PubMed ID: 30275013)
21. The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
Palacios AR; Mojica MF; Giannini E; Taracila MA; Bethel CR; Alzari PM; Otero LH; Klinke S; Llarrull LI; Bonomo RA; Vila AJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348667
[TBL] [Abstract][Full Text] [Related]
22. Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.
Papp-Wallace KM; Becka SA; Taracila MA; Winkler ML; Gatta JA; Rholl DA; Schweizer HP; Bonomo RA
Antimicrob Agents Chemother; 2016 Feb; 60(2):777-88. PubMed ID: 26596949
[TBL] [Abstract][Full Text] [Related]
23. Structural and Kinetic Insights into the "Ceftazidimase" Behavior of the Extended-Spectrum β-Lactamase CTX-M-96.
Ghiglione B; Rodríguez MM; Herman R; Curto L; Dropa M; Bouillenne F; Kerff F; Galleni M; Charlier P; Gutkind G; Sauvage E; Power P
Biochemistry; 2015 Aug; 54(32):5072-82. PubMed ID: 26228623
[TBL] [Abstract][Full Text] [Related]
24. Removal of the Side Chain at the Active-Site Serine by a Glycine Substitution Increases the Stability of a Wide Range of Serine β-Lactamases by Relieving Steric Strain.
Stojanoski V; Adamski CJ; Hu L; Mehta SC; Sankaran B; Zwart P; Prasad BV; Palzkill T
Biochemistry; 2016 May; 55(17):2479-90. PubMed ID: 27073009
[TBL] [Abstract][Full Text] [Related]
25. Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 beta-lactamase in hypermutable Escherichia coli strains.
Stepanova MN; Pimkin M; Nikulin AA; Kozyreva VK; Agapova ED; Edelstein MV
Antimicrob Agents Chemother; 2008 Apr; 52(4):1297-301. PubMed ID: 18212109
[TBL] [Abstract][Full Text] [Related]
26. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency.
Soeung V; Lu S; Hu L; Judge A; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2020 Dec; 295(52):18239-18255. PubMed ID: 33109613
[TBL] [Abstract][Full Text] [Related]
27. Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes.
Nukaga M; Kumar S; Nukaga K; Pratt RF; Knox JR
J Biol Chem; 2004 Mar; 279(10):9344-52. PubMed ID: 14660590
[TBL] [Abstract][Full Text] [Related]
28. Combination of Amino Acid Substitutions Leading to CTX-M-15-Mediated Resistance to the Ceftazidime-Avibactam Combination.
Compain F; Dorchène D; Arthur M
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941650
[TBL] [Abstract][Full Text] [Related]
29. Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
Endimiani A; Doi Y; Bethel CR; Taracila M; Adams-Haduch JM; O'Keefe A; Hujer AM; Paterson DL; Skalweit MJ; Page MG; Drawz SM; Bonomo RA
Biochemistry; 2010 Feb; 49(5):1014-23. PubMed ID: 19938877
[TBL] [Abstract][Full Text] [Related]
30. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK
Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888
[TBL] [Abstract][Full Text] [Related]
31. Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M β-lactamase.
Judge A; Hu L; Sankaran B; Van Riper J; Venkataram Prasad BV; Palzkill T
Commun Biol; 2023 Jan; 6(1):35. PubMed ID: 36635385
[TBL] [Abstract][Full Text] [Related]
32. Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance.
Lu S; Montoya M; Hu L; Neetu N; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2023 May; 299(5):104630. PubMed ID: 36963495
[TBL] [Abstract][Full Text] [Related]
33. Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.
Kimura S; Ishiguro M; Ishii Y; Alba J; Yamaguchi K
Antimicrob Agents Chemother; 2004 May; 48(5):1454-60. PubMed ID: 15105092
[TBL] [Abstract][Full Text] [Related]
34. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
Cartelle M; del Mar Tomas M; Molina F; Moure R; Villanueva R; Bou G
Antimicrob Agents Chemother; 2004 Jun; 48(6):2308-13. PubMed ID: 15155242
[TBL] [Abstract][Full Text] [Related]
35. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
[TBL] [Abstract][Full Text] [Related]
36. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
Kimura S; Ishii Y; Tateda K; Yamaguchi K
Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
[TBL] [Abstract][Full Text] [Related]
37. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
38. Multiple substitutions lead to increased loop flexibility and expanded specificity in
Harper TM; June CM; Taracila MA; Bonomo RA; Powers RA; Leonard DA
Biochem J; 2018 Jan; 475(1):273-288. PubMed ID: 29229762
[TBL] [Abstract][Full Text] [Related]
39. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
Winkler ML; Papp-Wallace KM; Bonomo RA
J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
[TBL] [Abstract][Full Text] [Related]
40. Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.
Delmas J; Robin F; Carvalho F; Mongaret C; Bonnet R
Antimicrob Agents Chemother; 2006 Feb; 50(2):731-8. PubMed ID: 16436733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
